SEC Form D · filed September 11, 2025
Enlaza Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Shelley Chu · La Jolla, CADirectorTighe Reardon · La Jolla, CAExecJay Lichter · La Jolla, CADirectorMarcos Milla · La Jolla, CADirectorStephen Squinto · La Jolla, CADirectorJames N. Topper · La Jolla, CADirectorSergio Duron · La Jolla, CAExec · DirectorSanford Madigan · La Jolla, CAExecMark S. Rosen · Morristown, NJDirectorBrian M. Laden · Nashville, TNDirectorGerard M. Hayden, Jr · Nashville, TNExecRegan Bozman · San Francisco, CAExec · DirectorChristopher Rand · Nashville, TNDirectorStephen Squinto · La Jolla, CADirectorTyler M. Whitmore · Nashville, TNDirectorByron M. Smith · Nashville, TNExecMarc Chalfin · Miami Beach, FLExec · DirectorTheodore Woo · Miami Beach, FLExecMarc Chalfin · Miami Beach, FLExecEric C. Harweger · Ames, IADirectorDavid R. Phaup · Edwardsville, ILDirectorBruce E. Schneider · Venedy, ILDirectorMike D. Christensen · Edwardsville, ILDirectorVontobel Asset Management, Inc · NEW YORK, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗